Protalix BioTherapeutics Reviewing Partnering and Other Alternatives

Protalix BioTherapeutics Reviewing Partnering and Other Alternatives

[at noodls] – CARMIEL, Israel, Feb. 5, 2013 (GLOBE NEWSWIRE) — Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX) (TASE:PLX), confirms, in response to inquiries received this morning and a report appearing in the Israeli … more

View todays social media effects on PLX

View the latest stocks trending across Twitter. Click to view dashboard

See who Protalix is hiring next, click here to view

Share this post